Rituximab in Metastatic Melanoma

NCT01032122 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
9
Enrollment
OTHER
Sponsor class

Stopped the only reason is that recruitment was not sufficient to meet the planned patient numbers, because complete remissions are still infrequent.

Conditions

Interventions

Sponsor

Medical University of Vienna